3D bioprinting is a process to create tissues in various formats from micro-scale tissues to conventional multi- well tissues, where cell function and viability are maintained inside the printed concept.
The 3D micro- engineered environments open new channels for drug screening and essential studies of wound healing, angiogenesis, and stem cell niches. Many industries have already gained from multiple advancements in this field, leading to better and improved procedures world-wide.
The analysts forecast the Global 3D Bioprinting market to grow at a CAGR of 14.52 percent over the period 2013-2018.
The Global 3D Bioprinting market may be segmented to the technology available in the market: Ink jet Bioprinters, Valve-established Cell Printers, Laser-assisted Cell Printers, and Magnetic Levitation Bioprinters.
The report, the Global 3D Bioprinting Market 2014-2018, continues to be prepared according to an in-depth market analysis with input signals from business specialists. The report covers the EMEA and APAC areas, as well as the Americas; it also covers its growth prospects in the coming years and the Global 3D Bioprinting marketplace landscape. The report also contains a discussion of the key vendors operating in this market.